Cremophor-Induced Lupus Erythematosus-Like Reaction with Taxol Administration: A Case Report and Review of the Literature by Anthony Q. Pham, David Berz, Patricia Karwan, Gerald A. Colvin

Get full text

Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract by David Berz, Tina Rizack, Sherry Weitzen, Anthony Mega, Joseph Renzulli, Gerald Colvin

Get full text

Rlip Depletion Suppresses Growth of Breast Cancer by Chhanda Bose, Sushma Yadav, Sharad S. Singhal, Jyotsana Singhal, Ashly Hindle, Jihyun Lee, Naga K. S. Cheedella, Shabnam Rehman, Rakhshanda Layeequr Rahman, Catherine Jones, Meenakshi Darden, Philip T. Palade, David Berz, Sharda P. Singh, Sanjay Awasthi

Get full text

748 Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors by Daniel Olson, Manish Sharma, Erminia Massarelli, Jonathan Thompson, Rachel E Sanborn, Ralph J Hauke, Anthony W Tolcher, Elizabeth Davis, Conor Steuer, Muhammad Furqan, John Hamm, Doug Laux, David Berz, Wade T Iams, Vasily Andrianov, Brianne O’Neill, Yaiza Diaz De Durana

742 Phase 1/2 study of the bispecific 4–1BB and PD-L1 antibody INBRX-105 alone and in combination with pembrolizumab in select solid tumors by David Hong, Manish Sharma, Erminia Massarelli, Heather Kinkead, Naomi B Haas, Rachel E Sanborn, Ralph J Hauke, Anthony W Tolcher, Neal Akhave, Jong Chul Park, Jennifer Carlisle, John Hamm, Alexander I Spira, David Berz, Vasily Andrianov, Brianne O’Neill, Justin A Call, Frank Yung-Chin Tsai, D Ross Camidge